AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 223 min read$DGX

Quest Diagnostics Inc (DGX) (Q3 2026) Earnings Call Highlights: Double-Digit Revenue

Quest Diagnostics (DGX) reported Q3 2026 earnings with double-digit revenue growth, but faces challenges. PAMA reimbursement cuts may impact 2027 revenues by 1%. Total revenue per requisition declined 4.2% due to business mix, though it rose 1.7% excluding certain relationships. The company also reported a cybersecurity incident and higher fuel costs. CEO Jim Davis and CFO Sam Samad discussed growth strategies, partnerships, and margin improvements.

Original reporting
finance.yahoo.com
Published Oct 22, 2026, 9:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Quest Diagnostics Inc (DGX) (Q3 2026) Earnings Call Highlights: Double-Digit Revenue — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$DGXNeutralMed
01

Why it matters

The earnings release provides fresh guidance on PAMA impact and margin trends, offering traders new data to adjust forecasts.

02

Market read

Earnings data introduces new quantitative guidance on reimbursement headwinds and margin improvement, relevant for healthcare and diagnostics investors.

03

What to watch

Potential upside from Apple Health partnership rollout and Nova investment ramp‑up later in 2027.

Relevance 7/10Novelty 7/10Timing: post‑earnings call, immediate after‑hours reaction

Background

Quest Diagnostics reported Q3 results with revenue per requisition decline, PAMA reimbursement cuts, and a cybersecurity incident that has not disrupted operations.

Company-level read

Ticker impact

$DGXNeutralHigh confidence
Context

Q3 2026 earnings call disclosed double‑digit revenue growth, PAMA reimbursement cuts, a cybersecurity incident, and margin improvement details.

Expected impact

likely modest downside pressure from PAMA cuts and cyber risk, tempered by margin improvement and volume growth

Evidence & confidence

Guidance shows 1% revenue headwind from PAMA and a 10‑20 bps revenue drag in Q4, but operating margin rose 20 bps and volume grew 5% organic, suggesting limited net impact.

Market effects

Sector

Lab diagnostics sector may see modest pressure from Medicare PAMA adjustments, but firms with strong volume leverage could outperform.

Regional

U.S. healthcare services market; limited broader regional effect.

Global

Low; impact confined to U.S. diagnostics and related payer policies.

Counterpoint

What could challenge this read

Investors could view the cybersecurity incident as a catalyst for a short‑term pullback despite margin gains.

Key entities

  • company
    Quest Diagnostics Inc

    Provider of diagnostic testing services, ticker DGX.

  • partner
    Apple Health

    Integration partner for consumer test ordering.

Read at source← All news

StoryQuest Diagnostics posts Q3 2026 results, raises full‑year revenue and EPS outlook

Also covered by

6 outlets

Related articles

OCT 22
$DGXLow

Quest Diagnostics Reports Hack on IT System Used by Clients

Quest Diagnostics reported a cyber incident involving its Quanum Lab Services Manager system, potentially compromising certain patient records. The company paused access to the system while investigating but stated it has not materially disrupted operations. Quest notified U.S. law enforcement and is taking remedial measures. The company reported $11.04 billion in revenue for 2025. This follows recent cyber incidents at Abbott Labs, which is facing lawsuits.

govinfosecurity.com2 min
OCT 22
$DGXHighAI 8/10

What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call

Quest Diagnostics (DGX) reported Q3 operating income of $479M, up from $386M YoY. Adjusted EPS rose 15.4% to $3.00. The company expects full-year 2026 revenue of $12.065B-$12.105B. Quest plans to acquire select assets from a health system in the Northeastern U.S. and launched consumer health services via Apple Health app. Management addressed PAMA concerns, estimating a 1% revenue impact in 2027.

finance.yahoo.com2 min
OCT 22
$DGXHighAI 8/10

Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript

Quest Diagnostics (DGX) raised its full-year revenue and earnings guidance after Q3 2026, citing strong performance across physician, hospital, and consumer health channels. Key growth drivers include collaborations, acquisitions, and innovative solutions like Apple Health app integration. The company also announced plans to expand its Alzheimer's disease testing portfolio and improve operational efficiency through automation and AI.

finance.yahoo.com2 min
OCT 22
$DGXMedAI 8/10

Quest Diagnostics Incorporated Q3 2026 Earnings Call Summary

Quest Diagnostics reported 10% Q3 2026 revenue growth, driven by strong performance across commercial channels and partnerships. Consumer health revenue is expected to grow over 30% for the year. The company raised full-year 2026 revenue and EPS guidance, citing sustained demand and AI-driven efficiency gains. Management discussed potential PAMA-related revenue impacts and cybersecurity incidents. They plan to offset PAMA headwinds through cost efficiencies and volume growth.

finance.yahoo.com3 min